175 related articles for article (PubMed ID: 11378519)
1. Towards mitochondrial gene therapy: DQAsomes as a strategy.
Weissig V; Torchilin VP
J Drug Target; 2001; 9(1):1-13. PubMed ID: 11378519
[TBL] [Abstract][Full Text] [Related]
2. Approaches to mitochondrial gene therapy.
D'Souza GG; Weissig V
Curr Gene Ther; 2004 Sep; 4(3):317-28. PubMed ID: 15384945
[TBL] [Abstract][Full Text] [Related]
3. Cationic bolasomes with delocalized charge centers as mitochondria-specific DNA delivery systems.
Weissig V; Torchilin VP
Adv Drug Deliv Rev; 2001 Jul; 49(1-2):127-49. PubMed ID: 11377808
[TBL] [Abstract][Full Text] [Related]
4. Mitochondriotropic cationic vesicles: a strategy towards mitochondrial gene therapy.
Weissig V; Torchilin VP
Curr Pharm Biotechnol; 2000 Dec; 1(4):325-46. PubMed ID: 11467330
[TBL] [Abstract][Full Text] [Related]
5. Selective DNA release from DQAsome/DNA complexes at mitochondria-like membranes.
Weissig V; Lizano C; Torchilin VP
Drug Deliv; 2000; 7(1):1-5. PubMed ID: 10895413
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial leader sequence--plasmid DNA conjugates delivered into mammalian cells by DQAsomes co-localize with mitochondria.
D'Souza GG; Boddapati SV; Weissig V
Mitochondrion; 2005 Oct; 5(5):352-8. PubMed ID: 16154389
[TBL] [Abstract][Full Text] [Related]
7. In-vitro genetic modification of mitochondrial function.
Taylor RW; Chinnery PF; Turnbull DM; Lightowlers RN
Hum Reprod; 2000 Jul; 15 Suppl 2():79-85. PubMed ID: 11041515
[TBL] [Abstract][Full Text] [Related]
8. DQAsome/DNA complexes release DNA upon contact with isolated mouse liver mitochondria.
Weissig V; D'Souza GG; Torchilin VP
J Control Release; 2001 Aug; 75(3):401-8. PubMed ID: 11489326
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis for treatment of mitochondrial myopathies.
Taylor RW; Wardell TM; Lightowlers RN; Turnbull DM
Neurol Sci; 2000; 21(5 Suppl):S909-12. PubMed ID: 11382188
[TBL] [Abstract][Full Text] [Related]
10. Dequalinium-Derived Nanoconstructs: A Promising Vehicle for Mitochondrial Targeting.
Pawar A; Korake S; Gajbhiye KR
Curr Drug Deliv; 2021; 18(8):1056-1063. PubMed ID: 33475059
[TBL] [Abstract][Full Text] [Related]
11. Development of mitochondrial gene replacement therapy.
Khan SM; Bennett JP
J Bioenerg Biomembr; 2004 Aug; 36(4):387-93. PubMed ID: 15377877
[TBL] [Abstract][Full Text] [Related]
12. DQAsomes as the Prototype of Mitochondria-Targeted Pharmaceutical Nanocarriers : An Update.
Weissig V; Lozoya M; Yu N; D'Souza GGM
Methods Mol Biol; 2021; 2275():13-25. PubMed ID: 34118029
[TBL] [Abstract][Full Text] [Related]
13. Revolution in mitochondrial medicine.
Larsson NG; Luft R
FEBS Lett; 1999 Jul; 455(3):199-202. PubMed ID: 10437772
[TBL] [Abstract][Full Text] [Related]
14. DQAsome-mediated delivery of plasmid DNA toward mitochondria in living cells.
D'Souza GG; Rammohan R; Cheng SM; Torchilin VP; Weissig V
J Control Release; 2003 Sep; 92(1-2):189-97. PubMed ID: 14499196
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy by mitochondrial transfer.
Kagawa Y; Inoki Y; Endo H
Adv Drug Deliv Rev; 2001 Jul; 49(1-2):107-19. PubMed ID: 11377806
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial DNA and disease.
Suomalainen A
Ann Med; 1997 Jun; 29(3):235-46. PubMed ID: 9240629
[TBL] [Abstract][Full Text] [Related]
17. Organismal effects of mitochondrial dysfunction.
Naviaux RK; McGowan KA
Hum Reprod; 2000 Jul; 15 Suppl 2():44-56. PubMed ID: 11041512
[TBL] [Abstract][Full Text] [Related]
18. A synthetic mitochondrial-based vector for therapeutic purposes.
Renteln M
Med Hypotheses; 2018 Aug; 117():28-30. PubMed ID: 30077190
[TBL] [Abstract][Full Text] [Related]
19. Expression of GFP in the mitochondrial compartment using DQAsome-mediated delivery of an artificial mini-mitochondrial genome.
Lyrawati D; Trounson A; Cram D
Pharm Res; 2011 Nov; 28(11):2848-62. PubMed ID: 21833794
[TBL] [Abstract][Full Text] [Related]
20. New genetics of mitochondrial DNA diseases.
Poulton J
Br J Hosp Med; 1996 Jun 5-18; 55(11):712-6. PubMed ID: 8793140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
